Abstract
Threatened or occluded access grafts are a frequent complication in patients undergoing hemodialysis and are associated with increased length of stay, morbidity, mortality, and hospital costs. An ideal access is one that can be reliably developed, delivers an optimal dialysis dose, and is resistant to thrombosis, infection, and the need for re-intervention. Access grafts generally have a greater likelihood to initial successful use and greater success for access salvage, but are prone to frequent failure and shorter long term patency. Arteriovenous fistula, however, are associated with lower likelihood to initial successful use, but have longer patency rates with fewer long term complications. When faced with a threatened graft and a secondary arteriovenous fistula is feasible, the best management approach may be an intervention to initially save the threatened graft but plans should be in place to perform a secondary arteriovenous fistula. If a secondary arteriovenous fistula is not performed prior to the third intervention to save the threatened graft, likelihood of a successful conversion to a secondary arteriovenous fistula decreases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vachharajani TJ, Moossavi S, Jordan JR, Vachharajani V, Freedman BI, Burkart JM. Re-evaluating the fistula first initiative in octogenarians on hemodialysis. Clin J Am Soc Nephrol. 2011;6:1663–7.
Wang KL, Li SY, Chuang CL, Chen TW, Chen JY. Subfascial hematoma progressed to arm compartment syndrome due to a nontransposed brachiobasilic fistula. Am J Kidney Dis. 2006;48:990–2.
Howard AD, Howard RS, Goldstein SL, Meyer KB. Fistula first breakthrough initiative (FFBI): lessons about arteriovenous fistula prevalence goals. Am J Kidney Dis. 2013;61:523–5.
Lee HW, Allon M. When should a patient receive an arteriovenous graft rather than a fistula? Semin Dial. 2013;26:6–10.
Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48 Suppl 1:S176–247.
Allon M, Lok CE. Dialysis fistula or graft: the role for randomized clinical trials. Clin J Am Soc Nephrol. 2010;5:2348–54.
Sidawy AN, Spergel LM, Besarab A, Allon M, Jennings WC, Padberg Jr FT, Murad MH, Montori VM, O’Hare AM, Calligaro KD, et al. The society for vascular surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg. 2008;48:2s–5.
Sidawy AN. Arteriovenous hemodialysis access: the society for vascular surgery practice guidelines. J Vasc Surg. 2008;48:1s.
Schild AF. Maintaining vascular access: the management of hemodialysis arteriovenous grafts. J Vasc Access. 2010;11:92–9.
Slayden GC, Spergel L, Jennings WC. Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access. Semin Dial. 2008;21:474–82.
Salman L, Alex M, Unger SW, Contreras G, Lenz O, Asif A. Secondary autogenous arteriovenous fistulas in the “fistula first” era: results of a longterm prospective study. J Am Coll Surg. 2009;209:100–5.
Woo K, Doros G, Ng T, Farber A. Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts. J Vasc Surg. 2009;50:1405–11.e1–2.
Morosetti M, Cipriani S, Dominijanni S, Pisani G, Frattarelli D, Bruno F. Basilic vein transposition versus biosynthetic prosthesis as vascular access for hemodialysis. J Vasc Surg. 2011;54:1713–9.
Disbrow DE, Cull DL, Carsten 3rd CG, Yang SK, Johnson BL, Keahey GP. Comparison of arteriovenous fistulas and arteriovenous grafts in patients with favorable vascular anatomy and equivalent access to health care: is a reappraisal of the fistula first initiative indicated? J Am Coll Surg. 2013;216:679–85; discussion 685–6.
Davoudi M, Tayebi P, Beheshtian A. Primary patency time of basilic vein transposition versus prosthetic brachioaxillary access grafts in hemodialysis patients. J Vasc Access. 2013;14:111–5.
Lok CE, Sontrop JM, Tomlinson G, Rajan D, Cattral M, Oreopoulos G, Harris J, Moist L. Cumulative patency of contemporary fistulas versus grafts (2000-2010). Clin J Am Soc Nephrol. 2013;8:810–8.
Proctor G, Linas S. Type 2 pseudohypoaldosteronism: new insights into renal potassium, sodium, and chloride handling. Am J Kidney Dis. 2006;48:674–93.
Lomonte C, Buonvino N, Selvaggiolo M, Dassira M, Grasso G, Vernaglione L, Basile C. Sestamibi scintigraphy, topography, and histopathology of parathyroid glands in secondary hyperparathyroidism. Am J Kidney Dis. 2006;48:638–44.
Dogra G, Irish A, Chan D, Watts G. Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD. Am J Kidney Dis. 2006;48:926–34.
Wiederkehr MR, Nicosia RF, Munschauer C, Moe OW. An unusual case of urticaria and nephrotic syndrome. Am J Kidney Dis. 2006;48:506–12.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Flores, M.G., Lee, E.S. (2017). In Patients with Threatened or Occluded Dialysis Access Grafts, Is It Better to Salvage the Graft, or Create a New Site?. In: Skelly, C., Milner, R. (eds) Difficult Decisions in Vascular Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-319-33293-2_38
Download citation
DOI: https://doi.org/10.1007/978-3-319-33293-2_38
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33291-8
Online ISBN: 978-3-319-33293-2
eBook Packages: MedicineMedicine (R0)